chondroitin sulfate bioiberica

Chondroitin sulfate

For the symptomatic treatment of osteoarthritis and of joint discomfort
What is it?
  • Chondroitin sulfate is a glycosaminoglycan that constitutes an important structural component of the extracellular cartilage matrix and is responsible for its resistance to compression.
  • As we age, our cartilage starts to wear down and can lead to the onset of degenerative joint diseases like osteoarthritis. It has been proven that chondroitin sulfate can help slow this process.
  • Chondroitin sulfate-API is considered a Symptomatic Slow Acting Drug for Osteoarthritis.
  • For people suffering from joint disorders, such as osteoarthritis, it offers an effective and welcome treatment for joint pain.
  • Chondroitin sulfate-API is currently recommended by national and international therapeutic guidelines, with clinical trials showing its effectiveness in reducing joint pain and increasing mobility.
  • Chondroitin sulfate-API from Bioiberica is the chemical reference in the European Pharmacopoeia. It is available from bovine or porcine origin and capable for use for pharmaceuticals and injectable products.
  • Bioiberica also offers nutraceutical quality chondroitin sulfate which is predominantly used as a main ingredient in nutraceutical and veterinary formulations.
  • Our Chondroitin sulfate is compliant with the most restrictive and up-to-date monographs (EP, USP, JP, KP, RP) and is GMP certified.
Product information
  • SOURCE: Bovine or porcine cartilage.
  • PURITY: 90-100%
  • USES:
    • Pharmaceuticals
    • Injectable products
    • Nutraceuticals
  • QUALITIES: European, United States, Japanese, Korean and Russian Pharmacopoeias.
    • DMF for all qualities on demand
    • Europe: CEP (double) TSE
    • Japan:  Accreditation certified by foreign drug manufacturer
    • Korea: KFDA registration
    • GMP certificate
  • INDICATION: For the symptomatic treatment of osteoarthritis.
  • PRESENTATION: Hygroscopic powder - almost white.
  • RECOMMENDED DOSE: 800 mg/day (EU), 1.200 mg/day (US).
  • REGULATORY STATUS: Active Pharmaceutical Ingredient and Dietary Supplement Ingredient.
  • STORAGE AND PACKAGING: Store at room temperature. Packaged in a double bag in a 25 KG drum.
  • RE-ANALYSIS/EXPIRATION PERIOD: Re-analysis period of four years from the manufacture date.

Other products